Andrew Aronsohn
Section of Gastroenterology
Associate Professor of Medicine
Referring Physician Access Line: 1-877-DOM-2730


BS1998University of FloridaZoology
MD2002University of FloridaMedicine
Residency2005University of ChicagoInternal Medicine
Chief Resident2006University of ChicagoInternal Medicine
Fellowship2008University of ChicagoMedical Ethics
Senior Fellowship2009University of ChicagoMedical Ethics
Fellowship2009University of ChicagoGastroenterology

Academic Interests

Dr. Aronsohn's primary research interest involves studying hepatitis C treatment outcomes in this understudied population. In addition as part of the MacLean Center for Clinical Medical Ethics, he has also begun to work on ethical issues surrounding novel treatments for HCV.

Clinical Interests

General hepatology, liver transplantation, Hepatitis C

Representative Publications

  1. Aronsohn, A, Thistlethwaite, R, Segev, D, and Ross, LF, “How Different Conceptions of Risk are Used in the Organ Market Debate” American Journal of Transplantation, April 2010, Volume 10(4) 931-937
  2. Aronsohn, A and Reau, N, “Long-term Outcomes after Treatment with Interferon and Ribavirin in HCV Patients” Journal of Clinical Gastroenterology, Aug 2009,Volume 43(7) 661-71.

More Information

For more information about Dr. Andrew Aronsohn publications and research collaborations , please click here